Holen Sie sich die Stockscreener-App
5.48
7.03%
0.36
Schlusskurs vom Vortag:
$5.12
Offen:
$5.2
24-Stunden-Volumen:
141.92K
Relative Volume:
2.75
Marktkapitalisierung:
$29.62M
Einnahmen:
$15.66M
Nettoeinkommen (Verlust:
$1.28M
KGV:
41.48
EPS:
0.1321
Netto-Cashflow:
$-2.28M
1W Leistung:
+15.86%
1M Leistung:
+11.16%
6M Leistung:
+22.87%
1J Leistung:
-12.04%
1-Tages-Spanne:
$5.16
$5.53
1-Wochen-Bereich:
$4.41
$5.53
52-Wochen-Spanne:
$3.645
$21.40
Neuphoria Therapeutics Inc Stock (NEUP) Company Profile
Firmenname
Neuphoria Therapeutics Inc
Sektor
Branche
Telefon
781-439-5551
Adresse
100 SUMMIT DR, BURLINGTON
Compare NEUP vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
NEUP
Neuphoria Therapeutics Inc
|
5.48 | 27.67M | 15.66M | 1.28M | -2.28M | 0.1321 |
VRTX
Vertex Pharmaceuticals Inc
|
434.52 | 110.03B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
638.88 | 67.37B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.46 | 50.76B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
297.45 | 40.12B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
151.56 | 32.68B | 742.00K | -1.37B | -1.07B | -7.0731 |
Neuphoria Therapeutics Inc Stock (NEUP) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2023-09-28 | Hochstufung | H.C. Wainwright | Neutral → Buy |
| 2023-09-28 | Bestätigt | Maxim Group | Buy |
| 2022-01-10 | Eingeleitet | Berenberg | Buy |
| 2022-01-10 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2022-01-10 | Eingeleitet | Evercore ISI | Outperform |
| 2022-01-10 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Neuphoria Therapeutics Inc Aktie (NEUP) Neueste Nachrichten
NEUP Q1 2026 Earnings: Steeper-Than-Expected Loss Narrowing Fuels Post-Report RallyEarnings Surprise Score - Newser
NEUP Stock Moves Higher as Traders Focus on Neuphoria’s Cash Runway - Bez Kabli
Neuphoria Therapeutics Inc reports results for the quarter ended March 31Earnings Summary - TradingView
Why Neuphoria Therapeutics (NEUP) Just Dropped -6.89% — What to Watch 2026-05-17Real Trader Network - Newser
NEUP Downgraded by HC Wainwright & Co. -- Rating Updated to Neut - GuruFocus
Key facts: NEUP BNC210 Fails; SAD Halted, PTSD Paused; Q2 Loss $1.12 - TradingView
Neuphoria Therapeutics Inc expected to post a loss of $1.12 a shareEarnings Preview - TradingView
Deal Dispatch: GoPro Retains Houlihan Lokey In Strategic Review, Brookfield Buys World Freight Company, YesCare Corp. Bankruptcy - Benzinga
Neuphoria Therapeutics Inc. Q1 2026 10-Q Report: Financials, Risk Disclosures, and Strategic Outlook - Minichart
H.C. Wainwright Downgrades Neuphoria Therapeutics(NEUP.US) to Hold Rating - Moomoo
Neuphoria Therapeutics Inc. 3Q 2026: Revenue $0 EPS $(0.09) — 10-Q Summary - TradingView
Neuphoria Therapeutics Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2026 - marketscreener.com
Neuphoria Therapeutics Inc. (NEUP) Eps Diluted (TTM) - Zacks Investment Research
TradingKey - TradingKey
How Neuphoria Therapeutics (NEUP) performance compares to expectations (Slight Dip) 2026-05-11Reversal Picks - Newser
NEUP Shares Rise Pre-Market As It Explores Strategic Alternatives, Including Potential Acquisition - MSN
How sustainable is Neuphoria Therapeutics (NEUP) earnings momentum | Q1 2026: Better Than Expected - newser.com
How Neuphoria Therapeutics (NEUP) adapts when conditions change (Smart Money Flows) 2026-05-05Senior Analyst Forecasts - newser.com
NEUP Neuphoria Therapeutics reports narrower than expected Q1 2026 loss, shares climb 2.65 percent in today’s trading.Verified Analyst Reports - newser.com
Whats the outlook for Neuphoria Therapeutics Incs sectorInsider Selling & High Yield Equity Trading Tips - baoquankhu1.vn
Decliners Report: Is Neuphoria Therapeutics Inc impacted by rising rates2026 Institutional Moves & Verified Entry Point Detection - baoquankhu1.vn
Neuphoria Therapeutics Inc. (NEUP) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
New Highs: Whats the outlook for Neuphoria Therapeutics Incs sectorFed Meeting & Verified Momentum Stock Watchlist - baoquankhu1.vn
If You Invested $1,000 in Neuphoria Therapeutics Inc (NEUP) - Stock Titan
Earnings Report: Is Neuphoria Therapeutics Inc vulnerable to short sellers2026 Weekly Recap & Fast Moving Market Watchlists - baoquankhu1.vn
Big Money Moves: Is Neuphoria Therapeutics Inc a good ESG investment2026 Technical Patterns & Advanced Swing Trade Entry Plans - baoquankhu1.vn
Is Neuphoria Therapeutics (NEUP) Stock a Top Performer | Price at $4.36, Down 1.25%Community Buy Alerts - Newser
Why Did NEUP Stock Surge 64% Today? - MSN
How does macroeconomics affect Neuphoria Therapeutics (NEUP) Stock | Price at $4.78, Up 1.27%Open Trading Community - Newser
NEUP Stock Analysis: Neuphoria Therapeutics gains 7.04 percent to hit 4.41 mark - Newser
Fed Watch: Whats the outlook for Neuphoria Therapeutics Incs sectorQuarterly Market Summary & Risk Controlled Swing Alerts - baoquankhu1.vn
Aug Outlook: Is Neuphoria Therapeutics Inc a good ESG investment2026 Bull vs Bear & Daily Stock Momentum Reports - baoquankhu1.vn
Bull Run: What is the PEG ratio of Neuphoria Therapeutics Inc2026 Big Picture & Low Risk High Reward Trade Ideas - baoquankhu1.vn
NEUP Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Aug Mood: What is the PEG ratio of Neuphoria Therapeutics IncWeekly Trend Report & Low Volatility Stock Suggestions - baoquankhu1.vn
History Review: Can Neuphoria Therapeutics Inc beat the S P 500Weekly Earnings Recap & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Volatility Watch: Is Neuphoria Therapeutics Inc impacted by rising rates2026 Buyback Activity & Long-Term Growth Portfolio Plans - baoquankhu1.vn
Neuphoria Therapeutics Inc. (NASDAQ:NEUP) Short Interest Down 56.8% in February - Defense World
Big Picture: Can Neuphoria Therapeutics Inc. stock double in the next year2026 Support & Resistance & Technical Pattern Recognition Alerts - baoquankhu1.vn
Short Squeeze: What is Neuphoria Therapeutics Incs P E ratio telling us2025 Trading Volume Trends & Consistent Profit Focused Trading Strategies - baoquankhu1.vn
Aug Outlook: Can Neuphoria Therapeutics Inc maintain sales growthQuarterly Growth Report & Verified Entry Point Detection - baoquankhu1.vn
Can Neuphoria Therapeutics Inc maintain sales growthJuly 2025 Intraday Action & High Conviction Buy Zone Alerts - baoquankhu1.vn
Critical Analysis: Immunic (NASDAQ:IMUX) and Neuphoria Therapeutics (NASDAQ:NEUP) - Defense World
Head to Head Review: Neuphoria Therapeutics and Immunic - National Today
BNOX Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
Here's Why We're Not At All Concerned With Neuphoria Therapeutics' (NASDAQ:NEUP) Cash Burn Situation - Yahoo Finance
Neuphoria Therapeutics Inc. SEC 10-Q Report - TradingView
Neuphoria Therapeutics Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2025 - marketscreener.com
Is Neuphoria Therapeutics Inc. impacted by rising ratesJuly 2025 Final Week & High Conviction Investment Ideas - mfd.ru
Finanzdaten der Neuphoria Therapeutics Inc-Aktie (NEUP)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.98%
1.33%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):